Group One Trading’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28 Hold
2
– – ﹤0.01% 7402
2026
Q2
$44 Sell
2
-2
-50% -$42 ﹤0.01% 7434
2026
Q1
$56 Sell
4
-4,191
-100% -$60.7K ﹤0.01% 7447
2025
Q4
$64.7K Sell
4,195
-1,073
-20% -$12.6K ﹤0.01% 5378
2025
Q3
$45.5K Hold
5,268
– – ﹤0.01% 6042
2025
Q2
$52.6K Buy
5,268
+4,210
+398% +$143K ﹤0.01% 5535
2025
Q1
$93K Sell
1,058
-2,938
-74% -$258K ﹤0.01% 4652
2024
Q4
$371K Buy
3,996
+3,713
+1,312% +$320K ﹤0.01% 3416
2024
Q3
$20.7K Buy
283
+203
+254% +$13.1K ﹤0.01% 5213
2024
Q2
$4.66K Buy
+80
New +$53.1K ﹤0.01% 5984

Other funds holding JBIO

Group One Trading's JBIO Position: Q3 2026 in Review

Group One Trading held its Jade Biosciences (JBIO) position steady in Q3 2026 at 2 shares worth $28. The position accounts for ﹤0.01% of the portfolio, ranked #7402.

Group One Trading first reported a position in JBIO in Q2 2024 and has held it in 10 quarters since. The position peaked at $371K in Q4 2024. 162 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

  • Group One Trading held 2 shares of Jade Biosciences worth $28 as of Q3 2026.
  • Group One Trading left its Jade Biosciences share count unchanged in Q3 2026.
  • Jade Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7402 holding.
  • Group One Trading first reported a position in Jade Biosciences in Q2 2024 and has held it in 10 quarters since.
  • Group One Trading's Jade Biosciences position peaked at $371K in Q4 2024.
  • 162 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.